Back
Results - Announcements
Sales rise 19.76% to Rs 71.63 crore
Bharat Parenterals reports consolidated net loss of Rs 7.51 crore in the September 2024 quarter
29-Oct-2024, 04:54
Net loss of Bharat Parenterals reported to Rs 7.51 crore in the quarter ended September 2024 as against net profit of Rs 3.52 crore during the previous quarter ended September 2023. Sales rose 19.76% to Rs 71.63 crore in the quarter ended September 2024 as against Rs 59.81 crore during the previous quarter ended September 2023.
Net loss of Bharat Parenterals reported to Rs 7.51 crore in the quarter ended September 2024 as against net profit of Rs 3.52 crore during the previous quarter ended September 2023. Sales rose 19.76% to Rs 71.63 crore in the quarter ended September 2024 as against Rs 59.81 crore during the previous quarter ended September 2023.
| Particulars | Quarter Ended | ||
| Sep. 2024 | Sep. 2023 | % Var. | |
| Sales | 71.63 | 59.81 | 20 |
| OPM % | -10.69 | 7.22 | - |
| PBDT | -6.36 | 6.29 | PL |
| PBT | -15.37 | 4.54 | PL |
| NP | -7.51 | 3.52 | PL |
Powered by Capital Market - Live News